Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 3, 2009, Pages

  Jadhav, Ashok ^a   Torlakovic, Emina ^a   Ndisang, Joseph Fomusi ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

AP 1; DOCA salt hypertension; Fibronectin; Glomerulosclerosis; Heme oxygenase; Hypertrophy; Inflammation; Kidney; NF B

Indexed keywords

8 ISOPROSTANE; ANTIOXIDANT; CREATININE; CYCLIC GMP; DEOXYCORTICOSTERONE ACETATE; FERRITIN; FIBRONECTIN; HEME OXYGENASE; HEMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD PRESSURE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE CLEARANCE; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY HYPERTROPHY; KIDNEY INJURY; MALE; MONONUCLEAR CELL; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT; RENAL PROTECTION; RISK REDUCTION;

ANIMALS; BLOOD PRESSURE; CYCLIC GMP; DESOXYCORTICOSTERONE; FERRITINS; HEME OXYGENASE (DECYCLIZING); HEMIN; HYPERTENSION; HYPERTROPHY; KIDNEY; KIDNEY DISEASES; MALE; NEPHRECTOMY; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 66049154851     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00510.2007     Document Type: Article

References (57)

1. Alam J, Cai J, Smith A. Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5′ sequences are required for induction by heme or heavy metals. J Biol Chem 269: 1001-1009, 1994. (Pubitemid 24981976)
2. Apak R, Guclu K, Ozyurek M, Karademir SE, Altun M. Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method. Free Radic Res 39: 949-961, 2005. (Pubitemid 41227031)
3. Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N, Risler T, Vallon V, Wulff P, Kuhl D, Lang F. Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med 84: 737-746, 2006. (Pubitemid 44328065)
4. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 267: 18148-18153, 1992.
5. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
6. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
7. Buck M. Formulary update: hemin injection (Panhematin) was approved for the treatment of intermittent porphyria. In: Vancomycin: Old Controversies and New Issues. Pediatric Pharmacotherapy, edited by Borowitz SM. Charlottesville, VA: University of Virginia Children's Hospital, 1995.
8. Cowley BD Jr, Chadwick LJ, Grantham JJ, Calvet JP. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J Am Soc Nephrol 1: 1048-1053, 1991.
9. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA. 8-Epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95: 2492-2499, 1997. (Pubitemid 27233114)
10. Dworkin LD, Tolbert E, Recht PA, Hersch JC, Feiner H, Levin RI. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Hypertension 27: 245-250, 1996. (Pubitemid 26045922)
11. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res 36: 300-309, 1975.
12. Guo DF, Chenier I, Lavoie JL, Chan JS, Hamet P, Tremblay J, Chen XM, Wang DH, Inagami T. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 48: 453-459, 2006. (Pubitemid 44253740)
13. Hamaguchi A, Kim S, Izumi Y, Iwao H. Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats. J Am Soc Nephrol 11: 39-46, 2000. (Pubitemid 30020424)
14. Hernandez-Presa M, Bustos C, Ortego M, Tunon J, Renedo G, Ruiz-Ortega M, Egido J. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532-1541, 1997. (Pubitemid 27142812)
15. Hintze KJ, Theil EC. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc Natl Acad Sci USA 102: 15048-15052, 2005.
16. Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology 148: 1688-1696, 2007. (Pubitemid 46457130)
17. Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system. Am J Hypertens 17: 597-603, 2004.
18. Iwasaki K, Mackenzie EL, Hailemariam K, Sakamoto K, Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref-1 during erythroid differentiation of K562 cells. Mol Cell Biol 26: 2845-2856, 2006.
19. Jadhav A, Torlakovic E, Ndisang JF. Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52: 910-917, 2008.
20. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002.
21. Johnson FK, Durante W, Peyton KJ, Johnson RA. Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles. Am J Physiol Heart Circ Physiol 286: H1681-H1687, 2004. (Pubitemid 38525454)
22. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol Heart Circ Physiol 271: H1132-H1138, 1996. (Pubitemid 126832331)
23. Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, Kudo H, Sugi Y, Fukui D, Yasukawa H, Kuwahara F, Imaizumi T. Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res 29: 711-718, 2006. (Pubitemid 44605370)
24. Katz SA, Opsahl JA, Wernsing SE, Forbis LM, Smith J, Heller LJ. Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy. Am J Physiol Regul Integr Comp Physiol 278: R578-R586, 2000. (Pubitemid 30158115)
25. Kiemer AK, Vollmar AM, Bilzer M, Gerwig T, Gerbes AL. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol 33: 236-246, 2000. (Pubitemid 30485227)
26. Kopp EB, Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv Immunol 58: 1-27, 1995.
27. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54: 356-361, 2001. (Pubitemid 32458132)
28. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91: 5987-5991, 1994. (Pubitemid 24188267)
29. Lee KY, Ito K, Hayashi R, Jazrawi EP, Barnes PJ, Adcock IM. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. J Immunol 176: 603-615, 2006. (Pubitemid 43023309)
30. Li X, Meng Y, Wu P, Zhang Z, Yang X. Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat. Regul Pept 138: 15-25, 2007.
31. Manning RD Jr, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003. (Pubitemid 37464109)
32. Mark A, Hock T, Kapturczak MH, Agarwal A, Hill-Kapturczak N. Induction of heme oxygenase-1 modulates the profibrotic effects of transforming growth factor-beta in human renal tubular epithelial cells. Cell Mol Biol (Noisy-le-grand) 51: 357-362, 2005. (Pubitemid 41596312)
33. Mattii L, Segnani C, Cupisti A, D'Alessandro D, Moscato S, Meola M, Barsotti G, Marino M, Bianchi F, Dolfi A, Bernardini N. Kidney expression of RhoA, TGF-beta1, and fibronectin in human IgA nephropathy. Nephron Exp Nephrol 101: e16-e23, 2005. (Pubitemid 41159947)
34. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 60: 1366-1377, 2001. (Pubitemid 32960030)
35. Mosley K, Wembridge DE, Cattell V, Cook HT. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease. Kidney Int 53: 672-678, 1998. (Pubitemid 28124282)
36. Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156: 1527-1535, 2000. (Pubitemid 30646692)
37. Ndisang JF, Lane N, Jadhav A. Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 26: 1188-1199, 2008.
38. Ndisang JF, Wang R, Vannacci A, Marzocca C, Fantappie O, Mazzanti R, Mannaioni PF, Masini E. Haeme oxygenase-1 and cardiac anaphylaxis. Br J Pharmacol 134: 1689-1696, 2001. (Pubitemid 34038102)
39. Ndisang JF, Wu L, Zhao W, Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101: 3893-3900, 2003. (Pubitemid 36857864)
40. Ortiz PA, Garvin JL. Intrarenal transport and vasoactive substances in hypertension. Hypertension 38: 621-624, 2001.
41. Otsuka F, Ogura T, Yamauchi T, Sato M, Kataoka H, Kageyama J, Makino H. Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats. Kidney Blood Press Res 23: 35-41, 2000. (Pubitemid 29486338)
42. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Espinoza F, Pons H, Vaziri ND. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 68: 2131-2142, 2005. (Pubitemid 43117787)
43. Rodriguez JA, Lopez JM, Biglieri EG. DOCA test for aldosteronism: its usefulness and implications. Hypertension 3: II-102-II-106, 1981.
44. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of antinephritic action. Biochim Biophys Acta 1362: 252-262, 1997. (Pubitemid 28164178)
45. Sasaki T, Takahashi T, Maeshima K, Shimizu H, Toda Y, Morimatsu H, Takeuchi M, Yokoyama M, Akagi R, Morita K. Heme arginate pretreatment attenuates pulmonary NF-kappaB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction. Med Chem 2: 271-274, 2006. (Pubitemid 44083145)
46. Shimamura T. 11-Deoxycorticosterone-induced hypertension, glomerulosclerosis and renal arterial and arteriolar lesions. Jpn J Exp Med 58: 225-228, 1988. (Pubitemid 18268962)
47. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726-F736, 2000. (Pubitemid 30351074)
48. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 84: 5918-5922, 1987. (Pubitemid 17130420)
49. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987. (Pubitemid 17049750)
50. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosteroneinduced inflammation in the rat heart : role of oxidative stress. Am J Pathol 161: 1773-1781, 2002. (Pubitemid 35265535)
51. Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, Nagahama K, Aoki I, Ishigatsubo Y. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol 138: 237-244, 2004. (Pubitemid 39472439)
52. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol Renal Physiol 277: F882-F889, 1999. (Pubitemid 30046063)
53. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289: H701-H707, 2005. (Pubitemid 41129386)
54. Vehaskari VM. Developmental origins of adult hypertension: new insights into the role of the kidney. Pediatr Nephrol 22: 490-495, 2007.
55. Wang R, Shamloul R, Wang X, Meng Q, Wu L. Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48: 685-692, 2006.
56. Wang Y, Kramer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Kidney Int 68: 47-61, 2005. (Pubitemid 43181363)
57. Xia CF, Bledsoe G, Chao L, Chao J. Kalli1krein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 289: F622-F631, 2005. (Pubitemid 41208478)